ClinicalTrials.gov record
Completed Phase 4 Interventional Accepts healthy volunteers Results available

Mail Order Mifepristone Study

ClinicalTrials.gov ID: NCT03913104

Public ClinicalTrials.gov record NCT03913104. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Feasibility and Acceptability of Dispensing Mifepristone Via Mail Order Pharmacy

Study identification

NCT ID
NCT03913104
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Daniel Grossman, MD
Other
Enrollment
536 participants

Conditions and interventions

Interventions

  • Mifepristone Drug

Drug

Eligibility (public fields only)

Age range
15 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 4, 2020
Primary completion
Jul 29, 2023
Completion
Jul 29, 2023
Last update posted
Aug 13, 2024

2020 – 2023

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Highland Hospital Oakland California 94602
Children's Hospital Oakland Oakland California 94609
Planned Parenthood Rocky Mountains Denver Colorado 80218
Christiana Care Health System Wilmington Delaware 19899
Atlanta Comprehensive Wellness Clinic Atlanta Georgia 30324
Albert Einstein College of Medicine New York New York 10461
Southern Tier Women's Health Services Vestal New York 13850
Delaware County Women's Center Chester Pennsylvania 19013
Allegheny Reproductive Health Center Pittsburgh Pennsylvania 15206
Brown Family Medicine Pawtucket Rhode Island 02860
Lifespan Providence Rhode Island 02905

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03913104, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2024 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03913104 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →